NeoVentures品牌介绍
NeoVentures品牌介绍
品牌简介
eoVentures成立于2002年,现已成为适配体开发和应用领域的全球领导者。SELEX代表配体通过指数富集的系统(Systematic Evolution of Ligands by EXponential enrichment)。它是一种用于鉴定和分离特定核酸分子的技术,如DNA或RNA适体,它们可以以高亲和力和特异性结合到目标分子上。SELEX技术可以分离出具有强结合亲和力的特定适配体。
NeoVentures was founded in 2002 and has since become the world leader in aptamer development and applications.SELEX stands for Systematic Evolution of Ligands by EXponential enrichment.It is a technique used to identify and isolate specific nucleic acid molecules, such as DNA or RNA aptamers, that can bind to a target molecule with high affinity and specificity. SELEX can lead to the isolation of specific aptamers with strong binding affinities.
Main product
Aptamarker platform
相关推荐
评论列表共有 0 条评论
暂无评论
发表评论
取消回复
药科美专注生命科学产品进出口与技术服务